Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 11/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1758472 | 0.98 | MEN1 (0.47) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Bromide SCHEMBL3800998 | 0.98 | MEN1 (0.51) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Hydrochloric Acid SCHEMBL960558 | 0.98 | MEN1 (0.47) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL961671 | 0.94 | MEN1 (0.51) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL28349886 | 0.93 | MEN1 (0.44) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL28358357 | 0.93 | MEN1 (0.44) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5286003 | 0.92 | MEN1 (0.54) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5288554 | 0.92 | MEN1 (0.54) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5301568 | 0.92 | MEN1 (0.54) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5298507 | 0.92 | MEN1 (0.54) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085568-A | Ion gel electrolyte composition capable of being subjected to room-temperature in-situ spontaneous polymerization, electrolyte and application | — | 2026-05-26 | — | — | CN | claimed |
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-23 | — | — | US | claimed |
| CN-116457960-A | Secondary battery, electronic device, and vehicle | 株式会社半导体能源研究所 | 2023-07-18 | — | — | CN | claimed |
| WO-2022090843-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE AND VEHICLE | 株式会社半導体エネルギー研究所 | 2022-05-05 | — | — | WO | claimed |
| US-9267214-B2 | Aluminum recovery process | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-02-23 | — | — | US | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | claimed |
| WO-2009102419-A2 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2009-08-20 | — | — | WO | claimed |
| EP-0404188-B1 | Non-aqueous electrolytic aluminum plating bath composition | NISSHIN STEEL CO LTD (JP) | 1994-03-16 | — | — | EP | claimed |
| US-4904355-A | Plating bath for electrodeposition of aluminum and plating process making use of the bath | NISSHIN STEEL CO., LTD. (JP) | 1990-02-27 | — | — | US | claimed |
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-05-06 | — | — | US | disclosed |
| US-20240283023-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-08-22 | — | — | US | disclosed |
| WO-2024155617-A2 | COMPOSITIONS COMPRISING SUPRAMOLECULAR ASSEMBLIES OF PEPTIDE AMPHIPHILES AND ORGANIC CATIONS AND METHODS OF USE THEREOF | NORTHWESTERN UNIVERSITY (US) | 2024-07-25 | — | — | WO | disclosed |
| CN-118290346-A | Method for producing amide compound, and amide compound | 广荣化学株式会社 | 2024-07-05 | — | — | CN | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| US-20060164790-A1 | Electric double-layer capacitor | NANTONG JIANGHAI CAPACITOR CO., LTD (CN) | 2006-07-27 | — | — | US | disclosed |
| EP-1604378-A2 | ELECTRIC DOUBLE-LAYER CAPACITOR | Advanced Capacitor Technologies, Inc. (JP) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004079759-A2 | ELECTRIC DOUBLE-LAYER CAPACITOR | ADVANCED CAPACITOR TECHNOLOGIES, INC. (JP) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | NAAA, NIT2, PAM | MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | MEN1 1923/4885HSP90AA1 4529/4885KMT2A 2453/4885 |
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | VDAC3, VDAC2, SCO2 | MEN1 2332/4885HSP90AA1 2985/4885KMT2A 1910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.